We noticed you are on our UK page. Want to switch regions? Choose from the options:

Dr Daniel Ajzensztejn
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr-Daniel-Ajzensztejn.jpg

Dr Daniel Ajzensztejn

Dr Daniel Ajzensztejn
FRCR, MRCP, DPhil (PhD), MSc Oncology, BSc Pharmacology, MBBS, Consultant Clinical Oncologist

Languages spoken

English

Expert in

Lung cancer, Skin cancer

Overview

Centres

Milton Keynes
Milton Keynes

GenesisCare, Sunrise Parkway, Linford Wood, East, Milton Keynes MK14 6LS, UK

52.05838, -0.76101
/uk/our-centres/milton-keynes
Oxford
Oxford

Peters Way, Sandy Lane West, Oxford, OX4 6LB

51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
Immunotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Immunotherapy
Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Radiotherapy
Stereotactic ablative radiotherapy (SABR)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic ablative radiotherapy

Specialises in

Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung cancer
Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Skin cancer
Careerpositions

Career positions

Current position(s)

  • Consultant Clinical Oncologist at Milton Keynes and Portsmouth

Dr Ajzensztejn undertook a DPhil (PhD) at Oxford University where his research focused on ways to use the body’s own immune system to fight cancer. He continues to be involved in clinical research and is the principle investigator for a number of clinical trials.

He is dedicated to providing the best possible care for his patients and is actively involved in research and learning new techniques and treatment modalities for his patients.

He is affilitated with NHS Hospital and University Hospitals Oxford. 

Expertise and interests

Expertise

Interests

  • Lung cancer
  • Skin cancer
  • Harnessing the immune system to reject cancers through genetic modifications of tumour cells. Combining immunotherapy with radiotherapy.
  • lung cancer, lung malignancies, skin cancer, Stereotactic Ablative Body Radiotherapy, SABR, IMRT, Conformal Radiotherapy, Mesothelioma, Respiratory Medicine